Molecular Partners AG Sponsored ADR

MOLN Healthcare Biotechnology

In the quarter to June 2026, revenue fell 98.9%, EPS grew 34.3% and free cash flow grew 23.8%, each against the same quarter a year earlier.

3.56 0.09 −2.47%
Market cap
$143.5M
P/E
0.0×
Fwd P/E
−2.7×
Dividend yield
—
F-score
2/9
Altman Z
2.72
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
116.93 175.25 214.38 266.95 179.64 189.65 103.01 156.45 145.43 178.00
Total non-current assets
6.31 4.82 6.56 7.87 9.27 10.38 — — — —
Total Assets
123.24 180.07 220.94 274.82 188.92 200.04 108.18 158.32 — 180.49
Total current liabilities
13.31 12.25 16.06 18.08 51.28 61.51 29.49 37.62 14.43 15.46
Total non-current liabilities
12.97 6.94 8.36 10.31 20.26 24.16 — — — —
Total liabilities
26.28 19.19 24.42 28.39 71.53 85.68 52.37 64.75 28.26 47.36
Common Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Shareholders Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Total Debt
— — — 5.27 6.64 8.20 2.62 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates